SPOK - Spok Holdings, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Alexandria,
United States
Type: Equity
SPOK price evolution
SPOK
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $23.88 | $23.34 | $31.99 | |
| Short term investments | ||||
| Net receivables | $21.38 | $22.82 | $21.72 | $23.31 |
| Inventory | ||||
| Total current assets | $58.38 | $56.15 | $52.93 | $63.89 |
| Long term investments | ||||
| Property, plant & equipment | $15.59 | $16.23 | $17.11 | $17.85 |
| Goodwill & intangible assets | $99.17 | $99.17 | $99.17 | |
| Total noncurrent assets | $160.23 | $162.08 | $163.79 | |
| Total investments | ||||
| Total assets | $216.76 | $216.38 | $215.01 | $227.68 |
| Current liabilities | ||||
| Accounts payable | $3.94 | $5.42 | $3.81 | $5.97 |
| Deferred revenue | $25.24 | $25 | $26.3 | |
| Short long term debt | $3.35 | $3.77 | $4.18 | |
| Total current liabilities | $45.63 | $43.36 | $39.89 | $48.01 |
| Long term debt | $6.37 | $6.63 | $6.9 | |
| Total noncurrent liabilities | $14.81 | $14.96 | $15.9 | |
| Total debt | $9.73 | $10.4 | $11.09 | |
| Total liabilities | $60.47 | $58.16 | $54.85 | $63.91 |
| Shareholders' equity | ||||
| Retained earnings | $53.91 | $57.03 | $60.23 | $62.6 |
| Other shareholder equity | -$1.75 | -$1.77 | -$1.72 | -$1.76 |
| Total shareholder equity | $158.21 | $160.17 | $163.77 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $31.99 | $35.75 | $44.58 | $48.73 |
| Short term investments | $15 | $30 | ||
| Net receivables | $23.31 | $26.86 | $26.91 | $29.93 |
| Inventory | ||||
| Total current assets | $63.89 | $70.05 | $94.05 | $118.89 |
| Long term investments | ||||
| Property, plant & equipment | $17.85 | $22.1 | $22.57 | $21.83 |
| Goodwill & intangible assets | $99.17 | $99.17 | $99.17 | $109.77 |
| Total noncurrent assets | $163.79 | $174.43 | $154.1 | $158.41 |
| Total investments | $15 | $30 | ||
| Total assets | $227.68 | $244.48 | $248.15 | $277.29 |
| Current liabilities | ||||
| Accounts payable | $5.97 | $5.88 | $5.29 | $6.68 |
| Deferred revenue | $26.3 | $26.27 | $25.61 | $27.69 |
| Short long term debt | $4.18 | $5.1 | $5.41 | $5.26 |
| Total current liabilities | $48.01 | $53.45 | $55 | $57.44 |
| Long term debt | $6.9 | $10.6 | $11.88 | $9.46 |
| Total noncurrent liabilities | $15.9 | $18.95 | $19.46 | $19.24 |
| Total debt | $11.09 | $15.7 | $17.29 | $14.72 |
| Total liabilities | $63.91 | $72.4 | $74.46 | $76.68 |
| Shareholders' equity | ||||
| Retained earnings | $62.6 | $74.08 | $77.99 | $110.28 |
| Other shareholder equity | -$1.76 | -$1.91 | -$1.59 | -$1.45 |
| Total shareholder equity | $163.77 | $172.08 | $173.69 | $200.61 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $33.98 | $34.91 | ||
| Cost of revenue | $7.16 | $7.14 | ||
| Gross Profit | $26.82 | $27.77 | ||
| Operating activities | ||||
| Research & development | $9.36 | $9.25 | ||
| Selling, general & administrative | $11.57 | $12.13 | ||
| Total operating expenses | $22.36 | $22.88 | ||
| Operating income | $4.46 | $4.89 | ||
| Income from continuing operations | ||||
| EBIT | $4.85 | $5.14 | ||
| Income tax expense | $1.43 | $0.91 | ||
| Interest expense | ||||
| Net income | ||||
| Net income | $3.42 | $4.24 | ||
| Income (for common shares) | $3.42 | $4.24 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $139.03 | $134.53 | $142.15 | $148.18 |
| Cost of revenue | $26.82 | $28.27 | $32.57 | $28.54 |
| Gross Profit | $112.21 | $106.27 | $109.58 | $119.64 |
| Operating activities | ||||
| Research & development | $36.39 | $41.04 | $47.17 | $45.67 |
| Selling, general & administrative | $49.52 | $54.09 | $64.02 | $62.57 |
| Total operating expenses | $90.98 | $106.03 | $137.3 | $142.3 |
| Operating income | $21.23 | $0.24 | -$27.72 | -$22.66 |
| Income from continuing operations | ||||
| EBIT | $22.32 | $1 | -$27.33 | -$21.77 |
| Income tax expense | $6.66 | -$20.86 | -$5.15 | $22.45 |
| Interest expense | ||||
| Net income | ||||
| Net income | $15.67 | $21.86 | -$22.18 | -$44.23 |
| Income (for common shares) | $15.67 | $21.86 | -$22.18 | -$44.23 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $3.42 | $4.24 | $3.37 | |
| Operating activities | ||||
| Depreciation | $1.07 | $1.07 | $0.73 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.16 | $1.15 | $1.32 | |
| Total cash flows from operations | $7.42 | $2 | $11.79 | |
| Investing activities | ||||
| Capital expenditures | -$0.64 | -$0.88 | -$1 | |
| Investments | ||||
| Total cash flows from investing | -$2.35 | -$0.64 | -$0.88 | -$1 |
| Financing activities | ||||
| Dividends paid | -$20.05 | -$6.33 | -$7.39 | -$6.24 |
| Sale and purchase of stock | $0.13 | -$2.43 | $0.12 | |
| Net borrowings | ||||
| Total cash flows from financing | -$22.34 | -$6.2 | -$9.81 | -$6.12 |
| Effect of exchange rate | $0.02 | -$0.05 | $0.04 | $0.02 |
| Change in cash and equivalents | -$4.16 | $0.54 | -$8.65 | $4.69 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $15.67 | $21.86 | -$22.18 | -$44.23 |
| Operating activities | ||||
| Depreciation | $4.5 | $3.57 | $10.45 | $9.06 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $4.06 | $3.83 | $7.24 | $5.51 |
| Total cash flows from operations | $26.18 | $6.46 | $7.97 | $26.16 |
| Investing activities | ||||
| Capital expenditures | -$3.42 | -$3.78 | -$15.23 | -$14.71 |
| Investments | $15.03 | $15.01 | $0.14 | |
| Total cash flows from investing | -$3.42 | $11.26 | -$0.23 | -$14.57 |
| Financing activities | ||||
| Dividends paid | -$25.64 | -$25.01 | -$10.03 | -$9.77 |
| Sale and purchase of stock | -$1.03 | -$1.21 | -$1.73 | -$0.6 |
| Net borrowings | ||||
| Total cash flows from financing | -$26.68 | -$26.22 | -$11.75 | -$10.37 |
| Effect of exchange rate | $0.14 | -$0.32 | -$0.14 | $0.15 |
| Change in cash and equivalents | -$3.77 | -$8.83 | -$4.15 | $1.37 |
News
Fundamentals
| Market cap | $289.57M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 20.26M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.39 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.28 |
| Quick ratio | N/A |